Skip to content

AeviceMD for Detection of Wheeze in Pediatric and Adult Populations

A Pilot Study to Assess Aevice Medical Device for Detection of Wheeze in Pediatric and Adult Populations

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06691971
Enrollment
160
Registered
2024-11-18
Start date
2023-06-29
Completion date
2026-12-31
Last updated
2025-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Bronchial Disease, Chronic Respiratory Disease, Pediatric Asthma, Respiratory Tract Diseases, Subject Presenting Wheeze

Keywords

Wheeze, Auscultation, Wearable Medical Device

Brief summary

Respiratory signs and symptoms consisting of wheeze, cough, and breathlessness are obtained in a manual fashion through history taking and physical examination by the healthcare professional. Auscultation of the lung assesses airflow through the trachea-bronchial tree and is helpful in diagnosing various respiratory disorders. AeviceMD is a wearable device that can acquire and process lung sounds, thus assisting in the detection of abnormal lung sounds. The primary objective of this study is to determine if AeviceMD can detect wheeze of pediatrics and adults as accurately as a physician through auscultation. The secondary objective is to investigate if AeviceMD can be used for remote auscultation of breath sounds.

Interventions

DEVICEAeviceMD

The AeviceMD device will be placed on the patient to detect the presence of wheeze and perform auscultation.

Sponsors

Montefiore Medical Center
CollaboratorOTHER
Aevice Health Pte. Ltd.
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The subject is willing and/or parents/guardians are able to give informed consent for participation in the study. * Male or Female, aged ≥ 3 years. * Diagnosed with acute asthma exacerbation by an ED provider.

Exclusion criteria

* Any other significant disease or disorder which, in the opinion of the Investigator, may either put the subjects at risk because of participation in the study, or may influence the result of the study, or the subject's ability to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Wheeze is detected by physician and AeviceMD60 SecondsPrimary endpoint of wheeze will be captured in a binary fashion (i.e. PRESENT or NOT PRESENT) on the CRF by the physician during manual auscultation. AeviceMD will perform wheeze analysis on each 5 sec of recording.

Secondary

MeasureTime frameDescription
Respiratory sounds are detected and identified by onsite physician and offsite (remote) physician150 SecondsSecondary endpoint of normal, abnormal and absent breath breath sounds will be captured in a binary fashion (i.e. PRESENT or NOT PRESENT) on the CRF by the physician during manual auscultation - i.e. bronchovesicular, crackles. Normal, abnormal and absent breath sounds will be annotated in a binary fashion (i.e. PRESENT or NOT PRESENT) on the CRF by the independent physician during remote auscultation - i.e. bronchovesicular, crackles.

Countries

United States

Contacts

Primary ContactSunit P. Jariwala, Professor, M.D.
sjariwal@montefiore.org718-920-6089
Backup ContactCarlos L. Lutz, Assistant Professor, M.D.
clutz@montefiore.org718-920-6626

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026